Statutory Instrument 1993 No. 1890

      The Medicines (Products Other Than Veterinary Dmgs) (Prescription Only) Amendment Order 1993


      © Crown Copyright 1993

      The legislation contained on this web site is subject to Crown Copyright protection. It may be reproduced free of charge provided that it is reproduced accurately and that the source and copyright status of the material is made evident to users.

      It should be noted that the right to reproduce the text of Statutory Instruments does not extend to the Royal Arms and the Queen's Printer imprints.

      The text of this Internet version of the Statutory Instrument has been prepared to reflect the text as it was Made. The authoritative version is the Queen's Printer copy published by The Stationery Office Limited as the The Medicines (Products Other Than Veterinary Dmgs) (Prescription Only) Amendment Order 1993, ISBN 0110348907. Purchase this item. For details of how to obtain an official copy see How to obtain The Stationery Office Limited titles.

      To ensure fast access over slow connections, large documents have been segmented into "chunks". Where you see a "continue" button at the bottom of the page of text, this indicates that there is another chunk of text available.

 


STATUTORYINSTRUMENTS

1993 No. 1890

MEDICINES

The Medicines (Products Other Than Veterinary Dmgs) (Prescription Only) Amendment Order 1993

Made 23rd July 1993
Laid before Parliament 2nd August 1993
Coming into force 23rd August 1993

    The Secretary of State concerned with health in England, the Secretaries of State respectively concerned with health and with agriculture in Wales and in Scotland, the Minister of Agriculture, Fisheries and Food, the Department of Health and Social Services for Northern Ireland and the Department of Agriculture for Northern Ireland, acting jointly, in exercise of the powers conferred upon them by sections 58(1), (4)(a) and 129(4) of the Medicines Act 1968[1] or, as the case may be, those conferred by the said provisions and now vested in them[2], and of all other powers enabling them in that behalf, after consulting such organisations as appear to them to be representative of interests likely to be substantially affected by this Order, pursuant to section 129(6) of that Act, and after consulting and taking into account the advice of the Medicines Commission pursuant to sections 58(6) and 129(7) of that Act, hereby make the following Order:
    Citation, commencement and interpretation
        1.—(1)  This Order may be cited as the Medicines (Products Other Than Veterinary Drugs) (Prescription Only) Amendment Order 1993, and shall come into force on 23rd August 1993.

        (2)  In this Order—"the principal Order" means the Medicines (Products Other Than Veterinary Drugs) (Prescription Only) Order 1983[3].
    Amendment of article 3 of the principal Order
        2.    In article 3(1)(a) of the principal Order (medicinal products on prescription only), for "Article 4(1), (1A), (1B), (1C), (1D) and (1E)"there is substituted "Article 4(1) to (1J)".
    Amendment of article 4 of the principal Order
        3.    In article 4 of the principal Order (medicinal products that are not prescription only), the following paragraphs are inserted after paragraph (1E):
      "  (1F)  Notwithstanding article 3(1)(a), a medicinal product shall not be a prescription only medicine by reason that it contains the substance acrivastine where—
        (a) the medicinal product is sold or supplied in a container or package containing not more than 240 milligrams of acrivastine;
        (b) its container or package is labelled to show a maximum daily dose of 24 milligrams of acrivastine.

          (1G)  Notwithstanding article 3(1)(a), a medicinal product shall not be a prescription only medicine by reason that it contains the substance cetirizine where—
        (a) the medicinal product is sold or supplied in a container or package containing not more than 100 milligrams of cetirizine;
        (b) its container or package is labelled to show a maximum daily dose of 10 milligrams of cetirizine.

          (1H)  Notwithstanding article 3(1)(a), a medicinal product shall not be a prescription only medicine by reason that it contains the substance ketoprofen where—
        (a) the maximum strength of the ketoprofen in the medicinal product does not exceed two point five per cent.calculated in terms of weight in weight;
        (b) the medicinal product is sold or supplied in a container or package containing not more than 30 grams of the medicinal product;
        (c) the medicinal product is indicated only for treatment by external topical application, for rheumatic and muscular pain in adults and in children over the age of 12 years, for a maximum period of 7 days.

          (1I)  Notwithstanding article 3(1)(a), a medicinal product shall not be a prescription only medicine by reason that it contains the substance loratadine where—
        (a) the medicinal product is sold or supplied in a container or package containing not more than 100 milligrams of loratadine;
        (b) its container or package is labelled to show a maximum daily dose of 10 milligrams of loratadine.

          (1J)  Notwithstanding article 3(1)(a), a medicinal product shall not be a prescription only medicine by reason that it contains the substance terfenadine where—
        (a) the medicinal product is sold or supplied in a container or package containing not more than 1200 milligrams of terfenadine;
        (b) its container or package is labelled to show a maximum daily dose of 120 milligrams of terfenadine." .
    Amendment of Part I of Schedule 1 to the principal Order
        4.    In Part I of Schedule 1 to the principal Order (which lists substances which render a medicinal product a prescription only medicine except in circumstances also listed) the following substances are inserted at the appropriate points in the alphabetical order of the substances listed in column 1:
    Acemetacin

    Acitretin

    Aclarubicin Hydrochloride

    Acrivastine

    Adenosine

    Albendazole

    Aldesleukin

    Alfuzosin Hydrochloride

    Azithromycin

    Bambuterol Hydrochloride

    Cefixime

    Cefodizime Sodium

    Cefpodoxime Proxetil

    Celiprolol Hydrochloride

    Cetirizine

    Cilastatin Sodium

    Cilazapril

    Ciprofibrate

    Clarithromycin

    Colfosceril Palmitate

    Dalteparin Sodium

    Dexfenfluramine Hydrochloride

    Diclofenac Potassium

    Eflornithine Hydrochloride

    Enoxaparin Sodium

    Epirubicin Hydrochloride

    Epoetin Alfa

    Epoetin Beta

    Filgrastim

    Finasteride

    Flosequinan

    Fluticasone Propionate

    Formestane

    Fosfomycin

    Trometamol

    Fosinopril Sodium

    Gadoteridol

    Gestrinone

    Granisetron Hydrochloride

    Guanfacine Hydrochloride

    Halofantrine Hydrochloride

    Imipenem Hydrochloride

    Iomeprol

    Iopentol

    Iothalamic Acid

    Ioversol

    Ioxaglic Acid

    Ketorolac Trometamol

    Lacidipine

    Lamotrigine

    Lomefloxacin Hydrochloride

    Loratadine

    Mifepristone

    Mivacurium Chloride

    Moclobemide

    Molgramostim

    Mometasone Furoate

    Moracizine Hydrochloride

    Nafarelin Acetate

    Nitrendipine

    Norfloxacin

    Norgestimate

    Ofloxacin

    Ondansetron Hydrochloride

    Oxaprozin

    Oxitropium Bromide

    Oxybutynin Hydrochloride

    Paroxetine Hydrochloride

    Perfluamine

    Pergolide Mesylate

    Pravastatin Sodium

    Remoxipride Hydrochloride

    Risperidone

    Salmeterol Hydroxynaphthoate

    Sermorelin

    Sertraline Hydrochloride

    Sodium Clodronate

    Somatorelin Acetate

    Sultamicillin

    Sumatriptan Succinate

    Tazobactam Sodium

    Terfenadine

    Tibolone

    Tinzaparin

    Tolfenamic Acid

    Tropisetron Hydrochloride

    Tulobuterol

    Tulobuterol Hydrochloride

    Zuclopenthixol Acetate
    Amendment of Table A of Part IV of Schedule 1 to the principal Order
        5.    In Table A of Part IV of Schedule 1 to the principal Order (medicinal products specified by name and product licence number that are not prescription only medicines), immediately after the entry Zenoxone Ointment 0181/0032 there is inserted the following entry:
      "Zovirax Cold Sore Cream 0003/0304" .


Signed by authority of the Secretary of State for Health

Tom Sackville

Parliamentary Under Secretary of State, Department of Health

19th July 1993

John Redwood

Secretary of State for Wales

21st July 1993

Fraser of Carmyllie

Minister of State Scottish Office

20th July 1993
In witness whereof the Official Seal of the Minister of Agriculture, Fisheries and Food is hereto affixed on the

Gillian Shephard

Minister of Agriculture, Fisheries and Food

23rd July 1993.
Sealed with the Official Seal of the Department of Health and Social Services for Northern Ireland this

J. Harbison

Under Secretary

19th day of July 1993.
Sealed with the Official Seal of the Department of Agriculture for Northern Ireland this

W. J. Hodges

Permanent Secretary

19th day of July 1993.






EXPLANATORY NOTE

(This note is not part of the Order)
    This Order further amends the Medicines (Products Other Than Veterinary Drugs) (Prescription Only) Order 1983 "the principal Order" which specifies descriptions and classes of prescription only medicines subject to section 58(2) of the Medicines Act 1968, that is to say, medicinal products which (subject to exemptions) may be sold or supplied by retail only in accordance with a prescription given by an appropriate practitioner and which may be administered only by or in accordance with the directions of such a practitioner.
    The amendments made by this Order are as follows
      article 2 amends article 3(1)(a) of the principal Order consequentiaily on the changes made to article 4 of the principal Order;

      article 3 amends article 4 of the principal Order sp as to exempt certain products containing Acrivastine, Cetirizine, Ketoprofen 2.5%, Loratadine and Terfenadine from being prescription only medicines;

      article 4 amends Part I of Schedule 1 to the principal Order which lists substances which render a medicinal product a prescription only medicine except in circumstances also listed.



ISBN 0 11 034890 7




Notes:

[1] 1968 c. 67; see the meaning assigned to "the appropriate Ministers" by section 1(1) as amended. back

[2] In the case of Secretaries of State concerned with health in England and Wales by virtue of article 2(2) of, and Schedule 1 to, the Transfer of Functions (Wales) Order 1969 (S.I. 1969/388); in the case of the Secretary of State concerned with agriculture in Wales by virtue of article 2(3) of, and Schedule 1 to, the Transfer of Functions (Wales) (No. 1) Order 1978 (S.I. 1978/272); in the case of the Northern Ireland Departments by virtue of section 40 of, and Schedule 5 to, the Northern Ireland Constitution Act 1973 (c. 36), and section 1(3) of, and paragraph 2(1)(B) of Schedule 1 to, the Northern Ireland Act 1974 (c. 28). back

[3] S.I. 1983/1212, as amended by S.I. 1984/756, 1986/586, 1987/674 and 1250, 1988/2017, 1989/1852, 1991/962, 1992/1534 and 1992/2937. back

 

Other UK SIs | Home | National Assembly for Wales Statutory Instruments | Scottish Statutory Instruments | Statutory Rules of Northern Ireland | Her Majesty's Stationery Office

We welcome your comments on this site
© Crown copyright 1993
Prepared 20th September 2000